The 60^th Congress of the European Societies of Toxicology (EUROTOX 2026 ↗) will bring together scientists from academia, regulatory bodies and industry to exchange knowledge on the latest developments in toxicology and strengthen international and interdisciplinary collaboration. 

PARC will have a significant presence at EUROTOX 2026, bringing together communication, networking and scientific activities throughout the congress. 

A major highlight of PARC’s participation at EUROTOX 2026 will be the PARC SYNnet Booth, conceived as a dedicated space for networking, exchange and collaboration. The booth will increase the visibility of PARC activities and results, strengthen interactions with the wider toxicology community, and foster new synergies with external research projects, initiatives and organisations. It will also host the “Meet me @PARC” initiative, offering participants the opportunity to engage directly with PARC researchers, discuss scientific topics of common interest, learn more about ongoing activities and results, and explore potential avenues for future collaboration. 

Alongside these networking and communication activities, PARC researchers will contribute extensively to the EUROTOX 2026 scientific programme, demonstrating the breadth of research being developed across the Partnership. Presentations include: 

• Does the PBK model complexity in human oral exposure matter? Harmonization and comparative evaluation of physiological models for emerging chemical classes, presented by Carolina Vogs ↗ (Swedish University of Agricultural Sciences - SLU ↗, Sweden)
• Ensuring Data Transparency and FAIRness in Support of One Health Applications, presented by Uko Maran ↗ (University of Tartu ↗ - UT, Estonia) 
• RE-MIX: Options to assess and regulate chemical mixtures – A PARC cooperation towards regulatory solutions, and Identification of potential Food Additive Mixtures and Health Risk Assessment using the Modified Reference Point Index (mRPI) and the Mixture Allocation Factor (MAF), both presented by Veronika Karne ↗l (Austrian Agency for Health and Food Safety ↗ - AGES, Austria) 
• Early oxidative, mitochondrial, and genotoxic stress responses to tenuazonic acid in human esophageal cells, presented by Dino Grgic ↗ (University of Vienna ↗ – UNIVIE, Austria) 
• Differential immunomodulation by Alternaria mycotoxins: Effects on NF-κB signaling and cytokine expression in immune and intestinal cells, presented by Vanessa Partsch ↗ (University of Vienna – UNIVIE ↗, Austria) 
• Harmonizing inhalation exposure in PBK models for the interpretation of HBM data and aggregated exposure: a PARC initiative, presented by Aude Ratier ↗ (French National Institute for Industrial Environment and Risks - INERIS ↗, France) 
• Development of an In Vitro Multiculture Liver Fibrosis Model for Evaluating Metal-Induced Toxicity in the Working Environment, presented by Lina Wik ↗ (National Institute of Occupational Health - STAMI ↗, Norway) 
• Chemical Class-Specific Analysis of Model Predictions for Thyroid Receptor Antagonist Classification, presented by Viktor Drgan ↗ (National Institute of Chemistry ↗ - Slovenia) 
• Integrating New Approach Methodologies (NAMs) into regulatory workflows: insights from a series of case studies, presented by Cristina Catinari (Italian National Institute of Health - ISS ↗, Italy) 
• Are there safe BPA alternatives? A contribution to close data gaps on the genotoxicity and mutagenicity of BPA alternatives, presented by Ana Tavares ↗(Portuguese National Institute of Health Dr. Ricardo Jorge - INSA ↗, Portugal) 
• Uncertainty in Guideline-Compliant Data and Its Implications for Next-Generation Toxicology: A Focus on Genotoxicity, presented by Martin Paparella ↗ (Medical University of Innsbruck ↗, Austria) 
• Isoform specific and organ differences in the glucuronidation of BPS-MAE and TCBPA, two proposed alternatives to Bisphenol A (BPA), presented by Franca Maria Buratti ↗ (Italian National Institute of Health - ISS ↗, Italy) 
• From BPA to alternatives: do safer substitutes really exist? Evidence from human immune models, presented by Martina Iulini ↗ (University of Milan - UNIMI ↗, Italy) 
• Evolution of Alternaria toxins hazard assessment: Integrating Genotoxicity and Carcinogenicity evidence through mechanistic and in silico approaches, presented by Vasiliki Hatzi ↗ (Benaki Phytopathological Institute - BPI ↗, Greece) 
• A weight-of-evidence framework applied to Alternaria toxins based on the exploitation of in silico tools, presented by Dimitra Nikolopoulou ↗(Benaki Phytopathological Institute - BPI ↗, Greece) 
• Development of new approach methodologies (NAMs) for the identification of respiratory sensitizer chemicals applying co-culture and mono-culture models, presented by Rita Hargitai (National Centre for Public Health and Pharmacy - NNGYK ↗, Hungary)
•  Dermal Absorption in PBK Models: Current Approaches, Gaps and the Path to FAIR Implementation, presented by Monika Witala ↗ (Swedish Environmental Research Institute - IVL ↗, Sweden)
•  Unravelling immunomodulatory effects of BPA substitutes, presented by Nina Franko ↗ (Faculty of Pharmacy, University of Ljubljana ↗, Slovenia) 

For further information, registration details and the full scientific programme, please visit the official EUROTOX 2026 website ↗.